Insider · CIK 0001426479
DiPalma Stephen J.
Reports to the SEC for 8 companies · WORCESTER, MA
Transactions
7
Companies
8
Filings
4
CIK
0001426479
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2021-05-17 | Inozyme Pharma, Inc.Stock option (Right to Buy)A Award | — |
| 2016-07-29 | INTERLEUKIN GENETICS INCCommon Stock Warrant (right to buy)P Purchase | — |
| 2016-07-29 | INTERLEUKIN GENETICS INCP Purchase | +$9,999.938 |
| 2014-12-23 | INTERLEUKIN GENETICS INCP Purchase | +$25K |
| 2014-12-23 | INTERLEUKIN GENETICS INCCommon Stock Warrant (right to buy)P Purchase | — |
| 2009-01-15 | SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award | — |
| 2009-01-15 | SLSSELLAS Life Sciences Group, Inc. · Stock OptionA Award | — |
Recent filings
- 4DiPalma Stephen J.0001209191-21-033477SEC(opens sec.gov)
- 4INTERLEUKIN GENETICS INC0001144204-16-115762SEC(opens sec.gov)
- 4INTERLEUKIN GENETICS INC0001144204-14-076369SEC(opens sec.gov)
- 4DiPalma Stephen J.0001209191-09-003962SEC(opens sec.gov)
Companies
- Chemomab Therapeutics Ltd.Chief Financial OfficerCMMB
- Generation Bio Co.See RemarksGBIO
- Inozyme Pharma, Inc.Interim CFO
- INTERLEUKIN GENETICS INCInterim CFO
- Scorpius Holdings, Inc.Interim CFO
- SELLAS Life Sciences Group, Inc.CFO, EVP, SecretarySLS
- Solid Biosciences Inc.Interim CFOSLDB
- Spero Therapeutics, Inc.See RemarksSPRO
Address
C/O RXI PHARMACEUTICALS CORPORATION 60 PRESCOTT STREET
WORCESTER, MA, 01605